{"id":"W4297983491","doi":"10.1007/s12032-022-01772-2","title":"RETRACTED ARTICLE: TNFR2 antagonist and agonist: a potential therapeutics in cancer immunotherapy","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Immune cells in cancer","field":"Immunology and Microbiology","cited_by":8,"is_retracted":true,"has_abstract":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"FOXP3; Cancer research; Cancer; Immunology; Cancer immunotherapy; Agonist; Immunotherapy; Immunopharmacology; Medicine; Tumor necrosis factor alpha; Effector; Downregulation and upregulation; Receptor; Pharmacology; Biology; Internal medicine; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}